The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease Patients
- 1 September 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (3) , 863-868
- https://doi.org/10.1016/s0002-9440(10)65185-1
Abstract
No abstract availableKeywords
Funding Information
- American Foundation for Aging Research (AG00774, AG16835, GM42056, DK48831, CA77839, DK26657, AG05144, GM15431)
- Alzheimer's Association (AG00774, AG16835, GM42056, DK48831, CA77839, DK26657, AG05144, GM15431)
- Abercrombie Foundation (AG00774, AG16835, GM42056, DK48831, CA77839, DK26657, AG05144, GM15431)
- National Institutes of Health (AG00774, AG16835, GM42056, DK48831, CA77839, DK26657, AG05144, GM15431)
This publication has 33 references indexed in Scilit:
- Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's diseaseAnnals of Neurology, 1998
- Oxidative damage in Alzheimer'sNature, 1996
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimerʼs diseaseCurrent Opinion in Lipidology, 1995
- Radical AGEing in Alzheimer's diseaseTrends in Neurosciences, 1995
- Bioenergetic and oxidative stress in neurodegenerative diseasesLife Sciences, 1995
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology & Medicine, 1991